Hypotension
Conditions
Keywords
hemodialysis treatment, pump stimulation, reduce hypotensive episodes
Brief summary
For the end stage renal disease (ESRD) patients undergoing hemodialysis treatment, specifically, reflex mediated calf muscle pump stimulation has the potential to significantly reduce the number and magnitude of hypotensive episodes thus enhancing the effectiveness of the dialysis process. Fewer hemodialysis complications during the patient's hemodialysis treatment, would allow treatment sessions to continue to the prescribed volume removal, with much reduced patient recovery time, and the costs associated with this recovery.
Detailed description
Recruit individuals who consistently miss their dialysis goal. Maintain the goal over a six week period of time. Utilize exogenous calf muscle pump stimulation during each dialysis session to enhance fluid return from the lower limbs with the objective of assisting the patient in reaching ultrafiltration goal. Track number of hypotensive events during dialysis, as well as goal success.
Interventions
Stimulation of the postural reflex arc to activate the soleus muscle during dialysis
Sponsors
Binghamton University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. 18 years of age or older; 2. alert and oriented to time, place, and self; 3. able to read and speak the English language; 4. currently receiving hemodialysis treatment approximately 3-4 hour sessions, 3 times a week; 5. received hemodialysis treatments continuously for the several previous months; AND 6. consistently exhibits hypotensive symptoms during dialysis.
Exclusion criteria
1. receiving hemodialysis as a temporary treatment following a peritoneal dialysis complication or an episode of transplant rejection; 2. receiving hemodialysis at home; OR 3. if they have a Medical History of any the following conditions: deep venous thrombosis, uncontrolled hypertension, pulmonary embolus
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Achievement of ultrafiltration goal | 6 weeks | Fraction of dialysis treatments where microfiltration target was achieved during 6 week period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hypotensive events | 6 weeks | Number of hypotensive events experienced during dialysis over six week time period |
Outcome results
None listed